| Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial MR Blum, BTGM Sallevelt, A Spinewine, D O’Mahony, E Moutzouri, ... BMJ 374, 2021 | 116 | 2021 |
| Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial L Adam, E Moutzouri, C Baumgartner, AL Loewe, M Feller, ... BMJ open 9 (6), e026769, 2019 | 61 | 2019 |
| What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study-a primary care-based survey Z Rozsnyai, KT Jungo, E Reeve, RKE Poortvliet, N Rodondi, J Gussekloo, ... BMC Geriatrics 20 (1), 1-11, 2020 | 54 | 2020 |
| Sponsorship of national and regional professional paediatrics associations by companies that make breast-milk substitutes: evidence from a review of official websites LM Grummer-Strawn, F Holliday, KT Jungo, N Rollins BMJ open 9 (8), e029035, 2019 | 50 | 2019 |
| Potentially inappropriate medication and attitudes of older adults towards deprescribing A Achterhof, Z Rozsnyai, E Reeve, KT Jungo, C Floriani, R Poortvliet, ... PLoS ONE 15 (10), 2020 | 49 | 2020 |
| How general practitioners would deprescribe in frail oldest-old with polypharmacy—the LESS study S Mantelli, KT Jungo, Z Rozsnyai, E Reeve, CH Luymes, RKE Poortvliet, ... BMC family practice 19 (1), 169, 2018 | 39 | 2018 |
| Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy A Bhadhuri, P Kind, P Salari, KT Jungo, B Boland, S Byrne, S Hossmann, ... Health and Quality of Life Outcomes 18 (317), 2020 | 33 | 2020 |
| General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries KT Jungo, S Mantelli, Z Rozsnyai, A Missiou, B Gerasimovska Kitanovska, ... BMC Geriatrics 21 (19), 2021 | 29 | 2021 |
| Astana Declaration: A New Pathway for Primary Health Care KT Jungo, D Anker, L Wildisen International Journal of Public Health 65 (5), 511-512, 2020 | 29 | 2020 |
| Impact of the COVID-19 Pandemic on the Intensity of Health Services Use in General Practice: A Retrospective Cohort Study Y Rachamin, O Senn, S Streit, J Dubois, MJ Deml, KT Jungo International Journal of Public Health, 2021 | 28 | 2021 |
| Utilization and Spending on Potentially Inappropriate Medications by US Older Adults with Multiple Chronic Conditions using Multiple Medications KT Jungo, S Streit, JC Lauffenburger Archives of Gerontology and Geriatrics 93, 2021 | 27 | 2021 |
| The impact of the COVID-19 pandemic on the continuity of care for at-risk patients in Swiss primary care settings: A mixed-methods study MJ Deml, J Minnema, J Dubois, O Senn, S Streit, Y Rachamin, K Jungo Social Science & Medicine, 2022 | 24 | 2022 |
| ‘Optimising PharmacoTherapy In the multimorbid elderly in primary CAre’(OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial KT Jungo, Z Rozsnyai, S Mantelli, C Floriani, AL Löwe, F Lindemann, ... BMJ open 9 (9), e031080, 2019 | 24 | 2019 |
| Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity BTGM Sallevelt, CJA Huibers, JMJ Op Heij, ... Drugs & Aging, 2021 | 21 | 2021 |
| Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial KT Jungo, R Meier, F Valeri, N Schwab, C Schneider, E Reeve, M Spruit, ... BMC Family Practice 22 (1), 1-14, 2021 | 18 | 2021 |
| Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications KT Jungo, S Streit, JC Lauffenburger BMC Geriatrics 21 (1), 1-12, 2021 | 14 | 2021 |
| Megatrends in Healthcare: Review for the Swiss National Science Foundation’s National Research Programme 74 (NRP74) “Smarter Health Care” M Deml, KT Jungo, M Maessen, A Martani, A Ulyte Public Health Rev, 2022 | 12 | 2022 |
| Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial KT Jungo, AK Ansorg, C Floriani, Z Rozsnyai, N Schwab, O Stalder, ... BMJ 381 (e074054), 2023 | 9 | 2023 |
| Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study P Salari, C O’Mahony, S Henrard, P Welsing, A Bhadhuri, N Schur, ... PloS one 17 (4), e0265507, 2022 | 9 | 2022 |
| Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study KT Jungo, B Cheval, S Sieber, L Bernadette Wilhelmina Antonia, A Ihle, ... PLOS ONE, 2022 | 7 | 2022 |
